Medical treatment of patients with gynecologic cancer during the COVID-19 pandemic.
Int J Gynecol Cancer
; 31(8): 1154-1158, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1197273
ABSTRACT
BACKGROUND:
During the COVID-19 pandemic, cancer care had to be reorganized; national and international recommendations were published to manage anticancer treatments safely and to reduce the risk of SARS-CoV-2 infection for patients and health workers.OBJECTIVE:
To evaluate whether the adoption of recommendations for the management of patients with gynaecologic cancer receiving treatment during the pandemic resulted in containment of infections and continuing oncologic care.METHODS:
Based on the published recommendations, and according to the local Health Direction guidelines, we developed and drafted a security protocol to modify access of patients with gynaecologic cancer to the "Fondazione Policlinico Agostino Gemelli-IRCCS, Rome" between February 1 and April 30, 2020 and compared results with the corresponding 3 months of 2019.RESULTS:
Between February and April 2019, we registered 3254 admissions, including 2253 patients receiving intravenous chemotherapies, 298 receiving oral therapies, and 703 having hospital visits. Between February and April 2020, we registered 3213 admissions, including 2221 patients receiving intravenous chemotherapies, 401 receiving oral therapies, and 591 having hospital visits. Oral treatments and general visits were different in the two time periods (p<0.001). Despite the elevated patient flow, only one patient (0.1%) tested positive for COVID-19 and there were no cases among healthcare staff.CONCLUSIONS:
Based on the adopted security protocol we provided continuity of care for all patients and limited the spread of the COVID-19 infection.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Genital Neoplasms, Female
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Int J Gynecol Cancer
Journal subject:
Gynecology
/
Neoplasms
Year:
2021
Document Type:
Article
Affiliation country:
Ijgc-2020-002288
Similar
MEDLINE
...
LILACS
LIS